**Core Concept**
The term "bioavailability" refers to the fraction of an administered dose of unchanged drug that reaches the systemic circulation and is one of the principal pharmacokinetic properties of drugs. It is influenced by factors that affect the absorption, distribution, and metabolism of the drug.

**Why the Correct Answer is Right**
Bioavailability is reduced when a drug undergoes extensive first-pass metabolism, which occurs when a drug is metabolized by the liver before reaching the systemic circulation. This is often seen with orally administered drugs that are highly lipophilic and are rapidly metabolized by the hepatic cytochrome P450 enzymes, particularly CYP3A4. The presence of food in the stomach can also affect bioavailability by slowing gastric emptying and altering the pH, which can influence the solubility and absorption of the drug.

**Why Each Wrong Option is Incorrect**
**Option A:** First-pass metabolism is the correct answer, but this is not listed.
**Option B:** Poor solubility may affect absorption, but it does not directly reduce bioavailability.
**Option C:** Volume of distribution is a pharmacokinetic property that describes the extent of drug distribution between plasma and the rest of the body, but it does not directly affect bioavailability.

**Clinical Pearl / High-Yield Fact**
A mnemonic to remember the factors affecting bioavailability is "FAD": Food, Absorption, and Distribution.

**Correct Answer: D. First-pass metabolism. First-pass metabolism reduces bioavailability.**